Literature DB >> 17881070

Efficiency, reproducibility and agreement of five different hemodynamic measures for optimization of cardiac resynchronization therapy.

Zachary I Whinnett1, Justin E R Davies, Gemma Nott, Keith Willson, Charlotte H Manisty, Nicholas S Peters, Prapa Kanagaratnam, D Wyn Davies, Alun D Hughes, Jamil Mayet, Darrel P Francis.   

Abstract

BACKGROUND: Several hemodynamic measures have been used for optimization of the AV delay of cardiac resynchronization therapy (CRT), including pulse pressure (PP), systolic blood pressure (SBP) and cardiac output (CO). We aimed to determine whether these measures identify the same optimum and whether they have the same efficiency and reproducibility at identifying this optimum. METHODS AND
RESULTS: In 22 patients with cardiac resynchronization therapy, we adjusted the AV delay while atrially pacing at 110 bpm and simultaneously recording SBP, diastolic blood pressure (DBP), PP, mean arterial pressure (MAP) and CO. SBP, PP and CO all had essentially the same signal-to-noise ratios (15.4+/-5.4, 15.5+/-6.4, 15.3+/-7.4 respectively p=NS). In contrast, MAP and DBP had significantly worse signal-to-noise ratios than SBP (14.2+/-5.6, p=0.003 and 12.1+/-4.4, p<0.0001 respectively). The optimal AV delay was very similar between SBP, PP, MAP and DBP. For example, the optima identified by SBP correlated strongly with those identified by PP (r=0.94), MAP (r=0.96) and DBP (r=0.90). In contrast, the optima detected by CO was poorly related to these (e.g. r=0.36 with SBP optima). Reproducibility was best for optima detected by SBP followed by MAP and PP.
CONCLUSIONS: Essentially the same AV optimum is identified, regardless of whether the parameter chosen for maximization is SBP, PP, MAP or DBP. We conclude that optimizing the CRT AV delay using SBP gives the best combination of efficiency and reproducibility, with PP and MAP being reasonable alternatives.

Entities:  

Mesh:

Year:  2007        PMID: 17881070     DOI: 10.1016/j.ijcard.2007.08.004

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  AV interval optimization using pressure volume loops in dual chamber pacemaker patients with maintained systolic left ventricular function.

Authors:  Frank Eberhardt; Thorsten Hanke; Joern Fitschen; Matthias Heringlake; Frank Bode; Heribert Schunkert; Uwe K H Wiegand
Journal:  Clin Res Cardiol       Date:  2012-03-09       Impact factor: 5.460

2.  The acute effects of changes to AV delay on BP and stroke volume: potential implications for design of pacemaker optimization protocols.

Authors:  Charlotte H Manisty; Ali Al-Hussaini; Beth Unsworth; Resham Baruah; Punam A Pabari; Jamil Mayet; Alun D Hughes; Zachary I Whinnett; Darrel P Francis
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-11-17

Review 3.  Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization?

Authors:  Andreas Kyriacou; Punam A Pabari; Darrel P Francis
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 4.  Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods.

Authors:  Patrick Houthuizen; Frank A L E Bracke; Berry M van Gelder
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

5.  A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy.

Authors:  Andreas Kyriacou; Matthew E Li Kam Wa; Punam A Pabari; Beth Unsworth; Resham Baruah; Keith Willson; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Zachary I Whinnett; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

6.  Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally.

Authors:  Andreas Kyriacou; Punam A Pabari; Jamil Mayet; Nicholas S Peters; D Wyn Davies; P Boon Lim; David Lefroy; Alun D Hughes; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett
Journal:  Int J Cardiol       Date:  2013-10-16       Impact factor: 4.164

7.  Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant.

Authors:  S M Afzal Sohaib; Andreas Kyriacou; Siana Jones; Charlotte H Manisty; Jamil Mayet; Prapa Kanagaratnam; Nicholas S Peters; Alun D Hughes; Zachary I Whinnett; Darrel P Francis
Journal:  Europace       Date:  2015-04-07       Impact factor: 5.214

8.  Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function.

Authors:  Siana Jones; Joost Lumens; S M Afzal Sohaib; Judith A Finegold; Prapa Kanagaratnam; Mark Tanner; Edward Duncan; Philip Moore; Francisco Leyva; Mike Frenneaux; Mark Mason; Alun D Hughes; Darrel P Francis; Zachary I Whinnett
Journal:  Europace       Date:  2017-07-01       Impact factor: 5.214

9.  Noninvasive cardiac output and blood pressure monitoring cannot replace an invasive monitoring system in critically ill patients.

Authors:  John F Stover; Reto Stocker; Renato Lenherr; Thomas A Neff; Silvia R Cottini; Bernhard Zoller; Markus Béchir
Journal:  BMC Anesthesiol       Date:  2009-10-12       Impact factor: 2.217

10.  British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

Authors:  Zachary I Whinnett; S M Afzal Sohaib; Siana Jones; Andreas Kyriacou; Katherine March; Emma Coady; Jamil Mayet; Alun D Hughes; Michael Frenneaux; Darrel P Francis
Journal:  BMC Cardiovasc Disord       Date:  2014-04-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.